In one patient with a germinal center-like structure, PD-L1 was also expressed by adjacent glioma cells, suggesting that PD-1/PD-L1 interaction in the tumor microenvironment could be important for the immune effector response to SurVaxM in some patients [25]. The gene discussed is CD274; the disease is glioma.